SCHEMBL28733751

SCHEMBL28733751

Nc1nc(-c2ccc(OC(F)(F)F)cc2)no1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.54
NOTUM Q6P988 1/20 0.54
SCN10A Q9Y5Y9 1/20 0.51
CHRNA7 P36544 6/20 0.50
MAPT P10636 1/20 0.50
PKM P14618 1/20 0.50
XBP1 P17861 1/20 0.50
DPP4 P27487 2/20 0.46
DPP7 Q9UHL4 1/20 0.46
S1PR1 P21453 1/20 0.46
ADORA3 P0DMS8 1/20 0.43
KIT P10721 1/20 0.41
KDR P35968 1/20 0.41
FLT3 P36888 1/20 0.41
GSK3B P49841 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1259383 0.83 CASP3 (0.57) CASP3SCN10ACHRNA7MAPTDPP4
SCHEMBL29620888 0.81 GRM5 (0.45) CASP3NOTUMCHRNA7
SCHEMBL28733657 0.81 GRM5 (0.45) CASP3NOTUMCHRNA7
SCHEMBL22925912 0.80 NOTUM (0.61) CASP3NOTUMS1PR1
SCHEMBL18105085 0.79 CASP3 (0.53) CASP3SCN10ACHRNA7MAPTPKM
SCHEMBL1114128 0.78 SCN10A (0.61) CASP3SCN10ACHRNA7MAPTPKM
SCHEMBL16088931 0.78 DPP4 (0.61) CASP3SCN10ACHRNA7MAPTDPP4
SCHEMBL22897781 0.78 CASP3 (0.52) CASP3SCN10AMAPTDPP4S1PR1
SCHEMBL15498668 0.78 SCN10A (0.67) CASP3SCN10AMAPTPKMXBP1
SCHEMBL203702 0.77 S1PR1 (0.55) CASP3SCN10AMAPTPKMXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114450281-B Inhibitor compounds 辛塞拉治疗私人有限公司 2024-08-16 CN disclosed
EP-4003986-A1 INHIBITOR COMPOUNDS Cincera Therapeutics Pty Ltd (AU) 2022-06-01 EP disclosed
CN-114450281-A Inhibitor compounds 辛塞拉治疗私人有限公司 2022-05-06 CN disclosed